Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer's Disease [Yahoo! Finance]
Alpha Cognition Inc. (ACOG)
Company Research
Source: Yahoo! Finance
All launch activities delivered on-time and on-budget, positioning ZUNVEYL for success VANCOUVER, British Columbia & DALLAS, March 18, 2025 BUSINESS WIRE )--Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced the official commercial launch of ZUNVEYL, a new treatment for mild to moderate Alzheimer's disease. This milestone marks a major step forward in the company's mission to provide innovative and accessible solutions for patients and caregivers — and to deliver new hope to the millions impacted by Alzheimer's. With a highly experienced commercial team in place, including industry leaders with proven success in the long-term care market, Alpha Cognition is poised to make a powerful impact. The company's nationwide salesforce is fully deployed and actively engaging with healthcare providers to ensure that ZUNVEYL reaches the patients who need it most. The commercial strategy is specifi
Show less
Read more
Impact Snapshot
Event Time:
ACOG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACOG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACOG alerts
High impacting Alpha Cognition Inc. news events
Weekly update
A roundup of the hottest topics
ACOG
News
- Alpha Cognition (NASDAQ:ACOG) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.MarketBeat
- Alpha Cognition Inc. (ACOG) Discusses Commercial Adoption Metrics and Market Opportunity in Long-Term Care Transcript [Seeking Alpha]Seeking Alpha
- Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners [Yahoo! Finance]Yahoo! Finance
- Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan PartnersBusiness Wire
- Here's Why We're Not Too Worried About Alpha Cognition's (NASDAQ:ACOG) Cash Burn Situation [Yahoo! Finance]Yahoo! Finance
ACOG
Analyst Actions
- 12/19/25 - HC Wainwright
ACOG
Sec Filings
- 10/15/25 - Form 8-K/A
- 10/14/25 - Form 8-K
- 10/3/25 - Form SCHEDULE
- ACOG's page on the SEC website